
doi: 10.1038/nbt0202-121
pmid: 11821852
It took a leap of faith for researchers to believe that antisense technology might lead to novel medicines, but that commitment could soon pay off.
Drug Industry, Oligonucleotides, Antisense, Models, Biological, DNA, Antisense, Patents as Topic, RNA, Bacterial, Models, Chemical, Humans, RNA, Antisense, RNA, Messenger, Biotechnology
Drug Industry, Oligonucleotides, Antisense, Models, Biological, DNA, Antisense, Patents as Topic, RNA, Bacterial, Models, Chemical, Humans, RNA, Antisense, RNA, Messenger, Biotechnology
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 68 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
